⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 29, 2024GenesOpen Access

Unveiling the Mechanism of Compound Ku-Shen Injection in Liver Cancer Treatment through an Ingredient–Target Network Analysis

Wenkui Zou Jiazhen Liu Zexing Wei Chunhua Peng Ying Zhao Yue Ding Jifan Shi Juan Zhao

View Full Paper

Ask AI

Bookmark

Share

Abstract

Compound Ku-Shen Injection (CKI) is a traditional Chinese medicine preparation derived from Ku-Shen and Bai-Tu-Ling, commonly used in the adjunctive treatment of advanced cancers, including liver cancer. However, the underlying mechanisms of CKI's effectiveness in cancer treatment are not well defined.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zou et al. (2024) studied this question.

synapsesocial.com/papers/68e57074b6db643587511771 https://doi.org/10.3390/genes15101278

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Exploring Compound Kushen Injection’s Anticancer Properties in Hepatocellular Carcinoma: An Integrated Approach of Network Pharmacology, Bioinformatics, and Experimental Validation2025 · 1 citations
2Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacologyOriginal Research · 2020 · 33 citations
3Examining the Mechanisms of Huachansu Injection on Liver Cancer through Integrated Bioinformatics AnalysisOriginal Research · 2022 · 9 citations
4Validating the Target Functions and Synergistic Multi-Target, Multi-Pathway Action Mode of Compound Kushen Injection Using CRISPR/CAS2024 · 2 citations
5Exploring the Mechanism of Huachansu Injection for Lung Cancer Based on Network Pharmacology and Molecular Docking2025